AngioLab (XKRX:251280) Ending Cash Position : ₩54.5 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AngioLab Ending Cash Position?

AngioLab's Ending Cash Position for the quarter that ended in Dec. 2023 was ₩54.5 Mil.

AngioLab's quarterly Ending Cash Position declined from Dec. 2021 (₩2,648.4 Mil) to Dec. 2022 (₩337.0 Mil) and declined from Dec. 2022 (₩337.0 Mil) to Dec. 2023 (₩54.5 Mil).

AngioLab's annual Ending Cash Position declined from Dec. 2021 (₩2,648.4 Mil) to Dec. 2022 (₩337.0 Mil) and declined from Dec. 2022 (₩337.0 Mil) to Dec. 2023 (₩54.5 Mil).

AngioLab Ending Cash Position Historical Data

The historical data trend for AngioLab's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Ending Cash Position Chart

AngioLab Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

121.26

178.25

2,648.35

336.99

54.46

AngioLab Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Ending Cash Position	Get a 7-Day Free Trial			121.26	178.25	2,648.35	336.99	54.46

AngioLab Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

AngioLab's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	336.989	+	-282.526
	=	54.5

AngioLab's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	336.989	+	-282.526
	=	54.5

AngioLab Ending Cash Position Related Terms

Thank you for viewing the detailed overview of AngioLab's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN

Website

http://www.angiolab.co.kr

AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines